PubMed COVID-19 Clinical Care

CONCLUSION: Together, a single application of CoVac-1 elicits long-lived and broad SARS-CoV-2-specific T cell immunity, which further supports the current evaluation of our T cell activator in patients with congenital or acquired B cell defects.

Solid organ transplant (SOT) recipients with coronavirus disease-2019 (COVID-19) experience prolonged viral shedding, and they are forced to stay in the hospital because of the requirement for COVID-19 isolation. Here, we present two cases (lung and

[This corrects the article DOI: 10.1016/j.clicom.2022.10.001.].

CONCLUSIONS: The results indicate the importance of active lifestyles in reducing negative impacts of the fear of being infected with a disease during times of crisis such as outbreaks and ruminative thoughts on lifestyle. The findings of this study

This paper argues that methodological uncertainty, such as that experienced by the social research community through the COVID-19 pandemic (2020-2022) is, and has always been, a vital part of the research landscape. Whilst recognising the many

Understanding adaptive immunity against SARS-CoV-2 is a major requisite for the development of effective vaccines and treatments for COVID-19. CD4 ^(+) T cells play an integral role in this process primarily by generating antiviral cytokines and

The COVID-19 pandemic has highlighted the relevance of goods delivery in urban areas. However, this activity often generates negative environmental impact and several technologies have been proposed in recent years to reduce it, thus forming a

Covid immunization commenced on 2nd Feb 2021 in Pakistan and as of 7th Sep 2021, over 84 million vaccine doses were administered in Pakistan, of which 72% procured by the government, 22% received through Covax and 6% were donated. The vaccines rolled

The aim of this paper is two-fold. First, we investigate the nexus between investor attention to COVID-19 and daily returns in 59 countries. We use Google Search Volume Index to account for investor attention. Our empirical findings suggest that the

SARS-CoV-2 continues to evolve, even after implementation of public-wide vaccination, as can be observed by an increasing number of mutations over time. Compared to responses by the United States and European countries, the disease mitigation